Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy
出版年份 2012 全文链接
标题
Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy
作者
关键词
Breast cancer, Chemotherapy, Therapy monitoring, Immunogenic cell death, Biomarkers, HMGB1, RAGE, CA 15–3, CEA, Serum
出版物
TUMOR BIOLOGY
Volume 34, Issue 1, Pages 81-90
出版商
Springer Nature
发表日期
2012-09-15
DOI
10.1007/s13277-012-0513-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Relevance of circulating biomarkers for the therapy monitoring and follow-up investigations in patients with non-small cell lung cancer
- (2017) Vivian Barak et al. Cancer Biomarkers
- Estimation of prognosis by circulating biomarkers in patients with non-small cell lung cancer
- (2017) Stefan Holdenrieder et al. Cancer Biomarkers
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer
- (2011) Manfred Kaufmann et al. ANNALS OF SURGICAL ONCOLOGY
- Advanced Glycation End Products, Soluble Receptor for Advanced Glycation End Products, and Risk of Colorectal Cancer
- (2011) L. Jiao et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Evidence That Serum Levels of the Soluble Receptor for Advanced Glycation End Products Are Inversely Associated with Pancreatic Cancer Risk: A Prospective Study
- (2011) L. Jiao et al. CANCER RESEARCH
- HMGB1 and RAGE in Inflammation and Cancer
- (2010) Gary P. Sims et al. Annual Review of Immunology
- High-mobility group box 1 and cancer
- (2010) Daolin Tang et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer
- (2010) Tomáš Krechler et al. CLINICAL BIOCHEMISTRY
- Plasma Nucleosome Levels Might Predict Response to Therapy in Patients With Advanced Non–Small-Cell Lung Cancer
- (2010) Sachin Kumar et al. Clinical Lung Cancer
- Receptor for advanced glycation end products (RAGE) soluble form (sRAGE): a new biomarker for lung cance
- (2010) R. JING et al. NEOPLASMA
- Immunogenic cell death modalities and their impact on cancer treatment
- (2009) Oliver Kepp et al. APOPTOSIS
- Clinical use of circulating nucleosomes
- (2009) Stefan Holdenrieder et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Clinical Value of Serum HMGB1 Levels in Early Detection of Recurrent Squamous Cell Carcinoma of Uterine Cervix: Comparison with Serum SCCA, CYFRA21-1, and CEA Levels
- (2009) Xiugui Sheng et al. CROATIAN MEDICAL JOURNAL
- Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications
- (2009) A. Bierhaus et al. DIABETOLOGIA
- Serum cathepsin K and cystatin C concentration in patients with advanced non-small-cell lung cancer during chemotherapy.
- (2009) Wojciech Naumnik et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- HMGB1 loves company
- (2009) Marco E. Bianchi JOURNAL OF LEUKOCYTE BIOLOGY
- Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer
- (2009) Hye Chung et al. Journal of Translational Medicine
- RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation
- (2009) Louis J Sparvero et al. Journal of Translational Medicine
- Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer
- (2009) Guan-Hong Shang et al. RESPIRATORY MEDICINE
- Using extracellular biomarkers for monitoring efficacy of therapeutics in cancer patients: an update
- (2008) S. H. Beachy et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Molecular Interactions between Dying Tumor Cells and the Innate Immune System Determine the Efficacy of Conventional Anticancer Therapies
- (2008) L. Apetoh et al. CANCER RESEARCH
- Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in Monitoring First-Line Chemotherapy of Small Cell Lung Cancer
- (2008) S. Holdenrieder et al. CLINICAL CANCER RESEARCH
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
- (2008) C. M. Sturgeon et al. CLINICAL CHEMISTRY
- Alternative antibody for the detection of CA15-3 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access® BR Monitor assay on the UniCel® DxI 800 Immunoassay System
- (2008) Rafael Molina et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma
- (2008) B.-Q. Cheng et al. DIGESTIVE AND LIVER DISEASE
- Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE
- (2008) Vilma Urbonaviciute et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More